Alembic Pharmaceuticals Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.076x

Alembic Pharmaceuticals Limited cash flow conversion efficiency. Based on the latest financial reports, Alembic Pharmaceuticals Limited (APLLTD) has a cash flow conversion efficiency ratio of 0.076x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs4.03 Billion ≈ $43.57 Million USD) by net assets (Rs53.16 Billion ≈ $574.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Alembic Pharmaceuticals Limited (2011–2025)

Cash flow conversion efficiency of Alembic Pharmaceuticals Limited from 2011 to 2025. This chart illustrates how Alembic Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Alembic Pharmaceuticals Limited share price for real-time trading data and today's change.

Alembic Pharmaceuticals Limited Cash Flow Conversion Ratio Explained

Alembic Pharmaceuticals Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Alembic Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alembic Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Also see APLLTD company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Migros Ticaret AS
IS:MGROS
0.172x
Greentown China Holdings Limited
F:G7C
0.081x
Austevoll Seafood ASA
OL:AUSS
0.066x
Chow Tai Seng Jewellery Co Ltd
SHE:002867
0.026x
Flight Centre Travel Group Ltd
AU:FLT
-0.051x
China National Gold Group Gold Jewellery Co Ltd
SHG:600916
0.003x
Aksa Enerji Uretim AS
IS:AKSEN
0.018x
Ora Banda Mining Ltd
AU:OBM
0.452x

Annual Cash Flow Conversion Efficiency for Alembic Pharmaceuticals Limited (2011–2025)

The table below shows the annual cash flow conversion efficiency of Alembic Pharmaceuticals Limited from 2011 to 2025. Review how much free cash does Alembic Pharmaceuticals Limited generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs51.90 Billion
≈ $561.23 Million
Rs879.70 Million
≈ $9.51 Million
0.017x -89.83%
2024-03-31 Rs48.18 Billion
≈ $521.07 Million
Rs8.03 Billion
≈ $86.86 Million
0.167x +0.64%
2023-03-31 Rs43.70 Billion
≈ $472.65 Million
Rs7.24 Billion
≈ $78.29 Million
0.166x +57.07%
2022-03-31 Rs52.38 Billion
≈ $566.42 Million
Rs5.52 Billion
≈ $59.73 Million
0.105x -63.48%
2021-03-31 Rs50.67 Billion
≈ $547.97 Million
Rs14.63 Billion
≈ $158.26 Million
0.289x +105.16%
2020-03-31 Rs31.90 Billion
≈ $345.04 Million
Rs4.49 Billion
≈ $48.57 Million
0.141x -52.88%
2019-03-31 Rs27.18 Billion
≈ $293.94 Million
Rs8.12 Billion
≈ $87.81 Million
0.299x +112.32%
2018-03-31 Rs22.20 Billion
≈ $240.13 Million
Rs3.12 Billion
≈ $33.79 Million
0.141x -7.37%
2017-03-31 Rs19.01 Billion
≈ $205.61 Million
Rs2.89 Billion
≈ $31.23 Million
0.152x -73.87%
2016-03-31 Rs16.01 Billion
≈ $173.09 Million
Rs9.30 Billion
≈ $100.62 Million
0.581x +199.39%
2015-03-31 Rs8.85 Billion
≈ $95.67 Million
Rs1.72 Billion
≈ $18.58 Million
0.194x -44.47%
2014-03-31 Rs6.76 Billion
≈ $73.06 Million
Rs2.36 Billion
≈ $25.55 Million
0.350x -33.59%
2013-03-31 Rs5.03 Billion
≈ $54.39 Million
Rs2.65 Billion
≈ $28.64 Million
0.527x +47.78%
2012-03-31 Rs3.95 Billion
≈ $42.72 Million
Rs1.41 Billion
≈ $15.22 Million
0.356x +9.39%
2011-03-31 Rs2.95 Billion
≈ $31.93 Million
Rs961.81 Million
≈ $10.40 Million
0.326x --

About Alembic Pharmaceuticals Limited

NSE:APLLTD India Drug Manufacturers - Specialty & Generic
Market Cap
$1.71 Billion
Rs157.84 Billion INR
Market Cap Rank
#6478 Global
#294 in India
Share Price
Rs803.00
Change (1 day)
+0.65%
52-Week Range
Rs646.55 - Rs960.70
All Time High
Rs1247.70
About

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal healt… Read more